NIKA PHARMACEUTICALS INC. NIKA
Set alert
At close · Oct 30
- YTD
- -7.92%
- 1 year
- +16.59%
- Open
- 0.35
- Prev close
- 0.35
- Mkt cap
- 366.99M
- Vol
- 2.50K
- Avg vol
- 160
- EPS
- 0.00
- P/E
- 0.00
More statistics
- Low
- 0.35
- High
- 0.35
News
2 months ago globenewswire.com
Nika Pharmaceuticals, Inc. (OTCQB: NIKA) Funding Update
Nika Pharmaceuticals, Inc. (OTCQB: NIKA) updates its shareholders regarding ongoing negotiations for up to 50 million USD and expected funding timeline.
5 months ago globenewswire.com
Nika Pharmaceuticals, Inc. (OTCQB: NIKA) June 2026 Update
HENDERSON, Nev., June 04, 2026 (GLOBE NEWSWIRE) -- Nika Pharmaceuticals, Inc. (OTCQB: NIKA) is currently engaged in active discussions with several investors from Europe and the US who have…
8 months ago globenewswire.com
Nika Pharmaceuticals, Inc. (NIKA) Signed a Consultancy Agreement with MD Global Partners LLC
HENDERSON, Nev., March 06, 2026 (GLOBE NEWSWIRE) -- Nika Pharmaceuticals, Inc. (OTCQB: NIKA) announces that it has signed a consultancy agreement with MD Global Partners LLC, a leading…
11 months ago globenewswire.com
Nika Pharmaceuticals, Inc. (NIKA) Progress Update
HENDERSON, Nev., Dec. 03, 2025 (GLOBE NEWSWIRE) -- Nika Pharmaceuticals, Inc. (OTCQB: NIKA) appeared on The Street Reports podcast where CEO Dimitar Savov shared the progress the company has made…
1 year ago globenewswire.com
UPDATE - Nika Pharmaceuticals, Inc. to Present at the Life Sciences Virtual Investor Forum June 11th-12th
Company invites individual and institutional investors, as well as advisors and analysts, to attend online at VirtualInvestorConferences.com Company invites individual and institutional investors, as…
1 year ago globenewswire.com
Nika Pharmaceuticals, Inc. to Present at the Life Sciences Virtual Investor Forum June 11th-12th
Company invites individual and institutional investors, as well as advisors and analysts, to attend online at VirtualInvestorConferences.com Company invites individual and institutional investors, as…
1 year ago globenewswire.com
Nika Pharmaceuticals, Inc. (NIKA) Markets Analysis and €8.5 Billion Projected Revenue
Nika Pharmaceuticals, Inc. (OTCQB: NIKA) projects €8.5 Billion revenue from its distribution agreements for Nigeria, Ukraine, UAE, Iraq, Syria, and Jordan.
1 year ago globenewswire.com
Nika Pharmaceuticals, Inc. (NIKA) Latest Developments
Nika Pharmaceuticals, Inc. (OTCQB: NIKA)'s report on the therapeutic effect of ITV-1 on AIDS, Cancer, Hepatitis volunteers and Nika Europe factory progress
2 years ago globenewswire.com
Nika Pharmaceuticals, Inc. (NIKA) Signed a Distribution Agreement for Nigeria
Nika Pharmaceuticals, Inc. (OTCMKTS: NIKA) signed a distribution agreement for the Republic of Nigeria that can generate the company €7.9 billion revenue.